Notably, a combination of CSF MCP-1 with CSF Aβ42 levels and p-tau and t-tau proteins could predict the rate of decline and future conversion to Alzheimer’s disease in patients with mild cognitive impairment [157]. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.